DODECANEDIOYL DICHLORIDE
Product Information
Molecular Formula
C12H20Cl2O2
Molecular Weight
267.19
Description
DODECANEDIOYL DICHLORIDE exhibits unparalleled significance within the realm of the biomedical industry. Infused with remarkable versatility, it assumes the pivotal role of a reagent during the synthesis of pharmaceutical drugs and bioactive moieties. By virtue of its multifaceted nature, this compound embodies immense potential for advancing biomedical research, particularly in the innovative treatment modalities targeting afflictions like cancer and cardiovascular disorders.
Synonyms
DODECANEDIOYL DICHLORIDE; 1,10-Decanedicarboxylic acid dichloride; Dodecanedioic acid dichloride; Dodecanedioyl dichloride,98%
IUPAC Name
dodecanedioyl dichloride
SMILES
C(CCCCCC(=O)Cl)CCCCC(=O)Cl
InChI
InChI=1S/C12H20Cl2O2/c13-11(15)9-7-5-3-1-2-4-6-8-10-12(14)16/h1-10H2
InChI Key
CNXXEPWXNDFGIG-UHFFFAOYSA-N
Boiling Point
140 °C0.5 mm Hg(lit.)
Flash Point
>230 °F
Purity
>98.0%(GC)(T)
Density
1.069
Appearance
Colorless to Light yellow to Light orange clear liquid
Refractive Index
n20/D 1.468(lit.)
Safety Information
Hazards
H290:
May be corrosive to metals.
H314:
Causes severe skin burns and eye damage.
May be corrosive to metals.
H314:
Causes severe skin burns and eye damage.
Precautionary Statement
P280:
Wear protective gloves/protective clothing/eye protection/face protection.
P301+P330+P331:
IF SWALLOWED:
Rinse mouth.
Do NOT induce vomiting.
P303+P361+P353:
IF ON SKIN (or hair):
Take off immediately all contaminated clothing. [As modified by IV ATP].
Rinse skin with water/shower.
P304+P340+P310:
IF INHALED:
Remove person to fresh air and keep comfortable for breathing.
Immediately call a POISON CENTER or doctor/physician.
P305+P351+P338+P310:
IF IN EYES:
Rinse cautiously with water for several minutes.
Remove contact lenses if present and easy to do. Continue rinsing.
Immediately call a POISON CENTER or doctor/physician.
P390:
P390
Wear protective gloves/protective clothing/eye protection/face protection.
P301+P330+P331:
IF SWALLOWED:
Rinse mouth.
Do NOT induce vomiting.
P303+P361+P353:
IF ON SKIN (or hair):
Take off immediately all contaminated clothing. [As modified by IV ATP].
Rinse skin with water/shower.
P304+P340+P310:
IF INHALED:
Remove person to fresh air and keep comfortable for breathing.
Immediately call a POISON CENTER or doctor/physician.
P305+P351+P338+P310:
IF IN EYES:
Rinse cautiously with water for several minutes.
Remove contact lenses if present and easy to do. Continue rinsing.
Immediately call a POISON CENTER or doctor/physician.
P390:
P390
Computed Properties
XLogP3
5.2
Hydrogen Bond Donor Count
0
Hydrogen Bond Acceptor Count
2
Rotatable Bond Count
11
Exact Mass
266.0840353 g/mol
Monoisotopic Mass
266.0840353 g/mol
Topological Polar Surface Area
34.1Ų
Heavy Atom Count
16
Formal Charge
0
Complexity
183
Isotope Atom Count
0
Defined Atom Stereocenter Count
0
Undefined Atom Stereocenter Count
0
Defined Bond Stereocenter Count
0
Undefined Bond Stereocenter Count
0
Covalently-Bonded Unit Count
1
Compound Is Canonicalized
Yes
Patents
| Publication Number | Title | Priority Date |
|---|---|---|
| JP-2022025328-A | How to make a semiconductor package | 2020-07-29 |
| JP-2022025329-A | Temporary fixing laminate for manufacturing semiconductor packages, carrier base material, and resin composition | 2020-07-29 |
| US-2021371731-A1 | Method for making photochromic contact lenses | 2020-06-02 |
| WO-2021245551-A1 | Method for making photochromic contact lenses | 2020-06-02 |
| JP-2021166984-A | Gas storage and release compounds | 2020-04-13 |
| US-2021284778-A1 | Photochromic polydiorganosiloxane vinylic crosslinkers | 2020-03-11 |
| US-2021284806-A1 | Photochromic polydiorganosiloxane vinylic crosslinkers | 2020-03-11 |
| WO-2021181307-A1 | Photochromic polydiorganosiloxane vinylic crosslinkers | 2020-03-11 |
| WO-2021181341-A1 | Photochromic polydiorganosiloxane vinylic crosslinkers | 2020-03-11 |
| US-2021246270-A1 | Actinically-crosslinkable polysiloxane-polyglycerol block copolymers and methods of making and use thereof | 2020-01-27 |
